Home > Cashflow Statement > AUROBINDO PHARMA

AUROBINDO PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
AUROBINDO PHARMA is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-1,269 Cr₹120 Cr₹800 Cr₹1,814 Cr₹-2,969 Cr

What is the latest Cash Flow from Financing Activities ratio of AUROBINDO PHARMA ?

The latest Cash Flow from Financing Activities ratio of AUROBINDO PHARMA is ₹-1,269 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-1,269 Cr
Mar2025₹120 Cr
Mar2024₹800 Cr
Mar2023₹1,814 Cr
Mar2022₹-2,969 Cr

How is Cash Flow from Financing Activities of AUROBINDO PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-1,269 Cr
Negative
Mar2025 ₹120 Cr
-85.04
Mar2024 ₹800 Cr
-55.89
Mar2023 ₹1,814 Cr
Positive
Mar2022 ₹-2,969 Cr -

Compare Cash Flow from Financing Activities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹95,516.4 Cr -0.7% 0.6% 48.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹422,283.0 Cr 0.2% -4.1% 5.5% Stock Analytics
DIVIS LABORATORIES ₹244,762.0 Cr -3.1% -1.6% 47.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,448.0 Cr -1.2% -5% 29.4% Stock Analytics
CIPLA ₹107,043.0 Cr 2.3% -2% -13.2% Stock Analytics
DR REDDYS LABORATORIES ₹102,820.0 Cr 2.2% 6.2% -2.5% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-0.7%

0.6%

48.5%

SENSEX

3.1%

1%

-9.1%


You may also like the below Video Courses